These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35912672)

  • 1. Central-line-associated bloodstream infections in a pediatric oncology and hematology hospital at home program.
    Raimbault SC; Domenech C; Fuhrmann C; Bertrand A
    Infect Control Hosp Epidemiol; 2023 May; 44(5):780-785. PubMed ID: 35912672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
    Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Line-Associated Bloodstream Infections in Children With Hematologic and Oncologic Diseases: First Prevalence Results From a University Hospital.
    Özalp Gerçeker G; Yardımcı F; Aydınok Y
    J Pediatr Oncol Nurs; 2019; 36(5):327-336. PubMed ID: 31027430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors.
    Rinke ML; Milstone AM; Chen AR; Mirski K; Bundy DG; Colantuoni E; Pehar M; Herpst C; Miller MR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1882-9. PubMed ID: 23881643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central Line Associated Blood Stream Infections in Pediatric Hematology/Oncology Patients With Different Types of Central Lines.
    Hord JD; Lawlor J; Werner E; Billett AL; Bundy DG; Winkle C; Gaur AH;
    Pediatr Blood Cancer; 2016 Sep; 63(9):1603-7. PubMed ID: 27198806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-level Intervention Program - A Quality Improvement Initiative to Decrease Central Line-Associated Bloodstream Infections in the Pediatric Acute and Hematology/Oncology Units.
    Santos KMB; Husain SS; Torres V; Huang CC; Jacob E
    J Pediatr Nurs; 2019; 48():106-113. PubMed ID: 31377635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results.
    Bundy DG; Gaur AH; Billett AL; He B; Colantuoni EA; Miller MR;
    Pediatrics; 2014 Dec; 134(6):e1678-85. PubMed ID: 25404721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.
    Kelada AS; Foster TB; Gagliano GC; Worley S; Tang A; Arakoni VA; Foster CB
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):377-383. PubMed ID: 35475427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bringing central line-associated bloodstream infection prevention home: CLABSI definitions and prevention policies in home health care agencies.
    Rinke ML; Bundy DG; Milstone AM; Deuber K; Chen AR; Colantuoni E; Miller MR
    Jt Comm J Qual Patient Saf; 2013 Aug; 39(8):361-70. PubMed ID: 23991509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenging the 48-Hour Rule-Out for Central Line-Associated Bloodstream Infections in the Pediatric Intestinal Failure Population: A Retrospective Pilot Study.
    Chang MI; Carlson SJ; Nandivada P; O'Loughlin AA; Potemkin AK; Cowan E; Mitchell PD; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2016 May; 40(4):567-73. PubMed ID: 25567785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Risk of Central Line-associated Bloodstream Infections in Pediatric Hematology/Oncology Patients.
    Kristinsdottir I; Haraldsson A; Gudlaugsson O; Thors V
    Pediatr Infect Dis J; 2021 Sep; 40(9):827-831. PubMed ID: 33990520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attributable length of stay and cost for pediatric and neonatal central line-associated bloodstream infections in Greece.
    Karagiannidou S; Zaoutis T; Maniadakis N; Papaevangelou V; Kourlaba G
    J Infect Public Health; 2019; 12(3):372-379. PubMed ID: 30616938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
    Chong CY; Ong RY; Seah VX; Tan NW; Chan MY; Soh SY; Ong C; Lim AS; Thoon KC
    J Paediatr Child Health; 2020 Jan; 56(1):123-129. PubMed ID: 31145505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central line maintenance bundles and CLABSIs in ambulatory oncology patients.
    Rinke ML; Bundy DG; Chen AR; Milstone AM; Colantuoni E; Pehar M; Herpst C; Fratino L; Miller MR
    Pediatrics; 2013 Nov; 132(5):e1403-12. PubMed ID: 24101764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.
    Pitiriga V; Bakalis J; Kampos E; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Jul; 11(1):96. PubMed ID: 35841083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
    Linder LA; Gerdy C; Jo Y; Wilson A
    J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of Supportive Care Program to Decrease CLABSI in a Middle East Pediatric Hematology and Oncology Inpatient Unit.
    Thompson K; Shaheen M
    J Pediatr Hematol Oncol Nurs; 2023; 40(5):313-324. PubMed ID: 37920979
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for central line-associated bloodstream infections in children with tunneled central venous catheters.
    Paioni P; Kuhn S; Strässle Y; Seifert B; Berger C
    Am J Infect Control; 2020 Jan; 48(1):33-39. PubMed ID: 31395289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of central line-associated bloodstream infections in a pediatric hematology/oncology population.
    Wilson MZ; Deeter D; Rafferty C; Comito MM; Hollenbeak CS
    Am J Med Qual; 2014; 29(6):484-90. PubMed ID: 24226650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.